14:09

CALQUENCE® (acalabrutinib) Safety Data – Dr Levy, MD

22:04

CALQUENCE® (acalabrutinib) ELEVATE-TN, Including 6-Year Median Follow-Up Data – Dr O’ Brien, MD

19:00

CALQUENCE® (acalabrutinib) ELEVATE-RR and ASCEND Data – Dr Ma, MD

18:35

CALQUENCE® (acalabrutinib) ACE-CL-001 (ibrutinib-intolerant cohort) – Dr Raval, MD

1:08:05

A Patient Story

12:20

CALQUENCE® (acalabrutinib) Perspectives: Dr Alexey Danilov, MD, PhD

20:01

CALQUENCE® (acalabrutinib) MAIC of ASCEND and ALPINE – Dr Skarbnik, MD

15:22

CALQUENCE® (acalabrutinib) ELEVATE-TN data, incl. High-Risk Subgroups – Dr Abutalib, MD